SG10201707152TA - A galactooligosaccharide composition for use in preventing or treating cognitive dysfunction and emotional disturbances in neuropsychiatry illnesses or ageing - Google Patents
A galactooligosaccharide composition for use in preventing or treating cognitive dysfunction and emotional disturbances in neuropsychiatry illnesses or ageingInfo
- Publication number
- SG10201707152TA SG10201707152TA SG10201707152TA SG10201707152TA SG10201707152TA SG 10201707152T A SG10201707152T A SG 10201707152TA SG 10201707152T A SG10201707152T A SG 10201707152TA SG 10201707152T A SG10201707152T A SG 10201707152TA SG 10201707152T A SG10201707152T A SG 10201707152TA
- Authority
- SG
- Singapore
- Prior art keywords
- neuropsychiatry
- illnesses
- ageing
- preventing
- cognitive dysfunction
- Prior art date
Links
- 230000032683 aging Effects 0.000 title 1
- 208000010877 cognitive disease Diseases 0.000 title 1
- 230000004970 emotional disturbance Effects 0.000 title 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 title 1
- 150000003271 galactooligosaccharides Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1305708.8A GB201305708D0 (en) | 2013-03-28 | 2013-03-28 | Novel use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201707152TA true SG10201707152TA (en) | 2017-10-30 |
Family
ID=48444941
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201507668UA SG11201507668UA (en) | 2013-03-28 | 2014-03-17 | A galactooligosaccharide composition for use in preventing or treating cognitive dysfunction and emotional disturbances in neuropsychiatry illnesses or ageing |
| SG10201707152TA SG10201707152TA (en) | 2013-03-28 | 2014-03-17 | A galactooligosaccharide composition for use in preventing or treating cognitive dysfunction and emotional disturbances in neuropsychiatry illnesses or ageing |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201507668UA SG11201507668UA (en) | 2013-03-28 | 2014-03-17 | A galactooligosaccharide composition for use in preventing or treating cognitive dysfunction and emotional disturbances in neuropsychiatry illnesses or ageing |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US11241449B2 (ja) |
| EP (1) | EP2978432B1 (ja) |
| JP (1) | JP6309612B2 (ja) |
| KR (2) | KR102235730B1 (ja) |
| CN (1) | CN105073120A (ja) |
| AR (1) | AR095738A1 (ja) |
| AU (1) | AU2014242798B2 (ja) |
| BR (1) | BR112015024625A2 (ja) |
| CA (1) | CA2908230C (ja) |
| ES (1) | ES2722852T3 (ja) |
| GB (2) | GB201305708D0 (ja) |
| HK (1) | HK1204451A1 (ja) |
| IL (1) | IL241844B (ja) |
| MX (1) | MX2015013699A (ja) |
| MY (1) | MY175533A (ja) |
| RU (1) | RU2663696C2 (ja) |
| SG (2) | SG11201507668UA (ja) |
| TW (1) | TWI507198B (ja) |
| WO (1) | WO2014155056A1 (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2492559B (en) * | 2011-07-05 | 2018-07-25 | Clasado Inc | Composition and method for preventing or reducing the risk of developing a syndrome |
| EP2886140A1 (en) * | 2013-12-17 | 2015-06-24 | University of Limerick | An apparatus for the extracorporeal treatment of blood |
| WO2016029113A1 (en) * | 2014-08-22 | 2016-02-25 | Abbott Laboratories | Methods of increasing endogenous production of beta-hydroxy-beta-methylbutyrate |
| CN113840611A (zh) * | 2019-05-15 | 2021-12-24 | N·V·努特里奇亚 | 用于治疗肠道屏障功能疾病的β-1,3’-半乳糖基乳糖 |
| CN115089596A (zh) * | 2022-06-20 | 2022-09-23 | 自然资源部第三海洋研究所 | 新琼寡糖用于制备治疗抑郁症产品的新用途 |
| GB2623335A (en) * | 2022-10-12 | 2024-04-17 | Clasado Res Services Limited | Compositions and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9923076D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
| DE19836339B4 (de) | 1998-08-11 | 2011-12-22 | N.V. Nutricia | Kohlenhydratmischung |
| GB0229015D0 (en) * | 2002-12-12 | 2003-01-15 | Novartis Nutrition Ag | New Compound |
| US20040265279A1 (en) * | 2003-05-08 | 2004-12-30 | Timothy Dinan | Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity |
| DE602004006133T3 (de) * | 2003-06-30 | 2014-12-24 | Clasado Inc. | Neue galactooligosaccharidzusammensetzung und herstellung davon |
| CN101095698B (zh) * | 2006-06-26 | 2010-12-01 | 青岛东海药业有限公司 | 酪酸梭菌防治便臭毒素引起的相关症状和疾病的用途 |
| ITMI20071214A1 (it) | 2007-06-15 | 2008-12-16 | S I I T Srl Servizio Internazi | Composizioni a base di componenti prebiotici ed immunogenici per la prevenzione e il trattamento di disturbi gastroenterici da disbiosi e/o alterazioni della normale flora intestinale |
| CN101998859B (zh) * | 2008-03-18 | 2014-03-05 | 亚历山大·弗拉基米罗维奇·季科夫斯基 | 用于预防与抗生素肠道给药相关的生态失调的药物组合物 |
| EP2110028A1 (en) * | 2008-04-15 | 2009-10-21 | Nestec S.A. | Bifidobacterium longum and hippocampal BDNF expression |
| GB0809921D0 (en) * | 2008-05-30 | 2008-07-09 | Clasado Inc | Product and process therefor |
| EP2405918B2 (en) | 2009-03-13 | 2020-09-02 | The Regents of The University of California | Prebiotic oligosaccharides |
| MX2012005015A (es) * | 2009-10-30 | 2012-06-12 | Prometheus Lab Inc | Metodos para diagnosticar sindrome de intestino irritable. |
| JP6006117B2 (ja) * | 2009-11-12 | 2016-10-12 | ネステク ソシエテ アノニム | 腸内微生物叢バランス及び健康を促進するための栄養組成物 |
| US20120276208A1 (en) | 2011-04-27 | 2012-11-01 | University Of South Australia | Acute cognitive and mood effects of plant polysaccharides in adult human subjects |
-
2013
- 2013-03-28 GB GBGB1305708.8A patent/GB201305708D0/en not_active Ceased
-
2014
- 2014-03-17 SG SG11201507668UA patent/SG11201507668UA/en unknown
- 2014-03-17 KR KR1020157030920A patent/KR102235730B1/ko active IP Right Grant
- 2014-03-17 AU AU2014242798A patent/AU2014242798B2/en active Active
- 2014-03-17 JP JP2016504734A patent/JP6309612B2/ja active Active
- 2014-03-17 RU RU2015146305A patent/RU2663696C2/ru not_active IP Right Cessation
- 2014-03-17 SG SG10201707152TA patent/SG10201707152TA/en unknown
- 2014-03-17 BR BR112015024625A patent/BR112015024625A2/pt not_active Application Discontinuation
- 2014-03-17 EP EP14712715.3A patent/EP2978432B1/en active Active
- 2014-03-17 MX MX2015013699A patent/MX2015013699A/es unknown
- 2014-03-17 ES ES14712715T patent/ES2722852T3/es active Active
- 2014-03-17 US US14/780,461 patent/US11241449B2/en active Active
- 2014-03-17 CN CN201480018975.5A patent/CN105073120A/zh active Pending
- 2014-03-17 MY MYPI2015703283A patent/MY175533A/en unknown
- 2014-03-17 WO PCT/GB2014/050829 patent/WO2014155056A1/en active Application Filing
- 2014-03-17 KR KR1020217009283A patent/KR20210038701A/ko not_active IP Right Cessation
- 2014-03-17 CA CA2908230A patent/CA2908230C/en active Active
- 2014-03-26 TW TW103111198A patent/TWI507198B/zh not_active IP Right Cessation
- 2014-03-26 AR ARP140101355A patent/AR095738A1/es unknown
- 2014-03-27 GB GB1405503.2A patent/GB2515865B/en active Active
-
2015
- 2015-05-26 HK HK15105009.1A patent/HK1204451A1/xx not_active IP Right Cessation
- 2015-09-24 IL IL241844A patent/IL241844B/en not_active IP Right Cessation
-
2022
- 2022-01-24 US US17/648,771 patent/US20220143054A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MY175533A (en) | 2020-07-01 |
| US11241449B2 (en) | 2022-02-08 |
| US20220143054A1 (en) | 2022-05-12 |
| KR20150135504A (ko) | 2015-12-02 |
| MX2015013699A (es) | 2016-05-31 |
| BR112015024625A2 (pt) | 2017-07-18 |
| TW201444562A (zh) | 2014-12-01 |
| GB201405503D0 (en) | 2014-05-14 |
| SG11201507668UA (en) | 2015-10-29 |
| GB201305708D0 (en) | 2013-05-15 |
| KR102235730B1 (ko) | 2021-04-02 |
| CA2908230A1 (en) | 2014-10-02 |
| HK1204451A1 (en) | 2015-11-20 |
| WO2014155056A1 (en) | 2014-10-02 |
| AU2014242798B2 (en) | 2018-07-05 |
| TWI507198B (zh) | 2015-11-11 |
| KR20210038701A (ko) | 2021-04-07 |
| ES2722852T3 (es) | 2019-08-19 |
| JP2016516743A (ja) | 2016-06-09 |
| EP2978432B1 (en) | 2019-02-20 |
| CN105073120A (zh) | 2015-11-18 |
| RU2663696C2 (ru) | 2018-08-08 |
| AU2014242798A1 (en) | 2015-10-08 |
| GB2515865B (en) | 2017-05-10 |
| AR095738A1 (es) | 2015-11-04 |
| CA2908230C (en) | 2021-04-13 |
| US20160045524A1 (en) | 2016-02-18 |
| GB2515865A (en) | 2015-01-07 |
| EP2978432A1 (en) | 2016-02-03 |
| IL241844B (en) | 2018-06-28 |
| RU2015146305A (ru) | 2017-05-04 |
| JP6309612B2 (ja) | 2018-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL267681A (en) | Selective grp94 inhibitors and their uses | |
| IL246023B (en) | Methods and preparations for the treatment of age-related conditions | |
| HK1214748A1 (zh) | 縫線設備及方法 | |
| HK1223975A1 (zh) | 含納米氣泡的組合物及其用途 | |
| IL246439A0 (en) | Ring-linked morphines and their use | |
| GB201317286D0 (en) | Composition and Use | |
| EP2987497A4 (en) | COMPOSITION FOR THE TREATMENT AND PREVENTION OF ISCHEMIC DAMAGES | |
| GB201305277D0 (en) | Novel combination and use | |
| IL241844B (en) | A preparation containing galacto-oligosaccharide for use in the prevention or treatment of impaired cognitive function and emotional disorders in neuropsychiatric diseases or old age | |
| IL240968A0 (en) | 1 ship modulators and related methods | |
| IL240248A0 (en) | Met-binding substances and their uses | |
| HK1255453A1 (zh) | 用於治療白血病的方法和組合物 | |
| EP2970557A4 (en) | POLYSILOXANE-MODIFIED POLYISOCYANATES FOR USE IN COATINGS | |
| EP2983459A4 (en) | CABINET AND CABINET GROUP COMPRISING IT | |
| IL241372B (en) | An h1 receptor antagonist and an h2 receptor antagonist for use in the treatment of diarrhea | |
| IL239659A0 (en) | ship 1 modulators and related methods | |
| EP3074029A4 (en) | ANTINEURO-INFLAMMATORY COMPOUNDS AND PROTECTORS IN ACHILLEA FRAGANTISSIMA | |
| EP3005068A4 (en) | TAP AND HOLDER | |
| SG10201706937UA (en) | Compositions for Use in Treating Eye Disorders Using Dipyridamole | |
| GB201307989D0 (en) | Novel combinations and use | |
| IL311363A (en) | Preparations for use in the treatment of cognitive impairment | |
| EP2951306A4 (en) | COMPOSITIONS AND METHOD FOR TREATING COMPLICATIONS RELATED TO DIABETES | |
| GB201322467D0 (en) | Composition and use | |
| GB201304271D0 (en) | Composition and apparatus | |
| GB201317642D0 (en) | Metal solubilisation and deposition |